cryptopleurine has been researched along with dcb 3503 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Han, G; Li, Z; Liu, Y; Meng, L; Wang, K; Wang, L; Wang, Q; Wang, Y; Wang, Z; Wu, M; Zhang, A | 1 |
| Chen, SR; Cheng, YC; Lee, KH; Wang, Y; Yang, X | 1 |
2 other study(ies) available for cryptopleurine and dcb 3503
| Article | Year |
|---|---|
Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents.
Topics: Alkaloids; Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Humans; Indolizines; Phenanthrolines; Quinolizines; Structure-Activity Relationship | 2012 |
Structure-activity relationships of cryptopleurine analogs with E-ring modifications as anti-hepatitis C virus agents.
Topics: Alkaloids; Allosteric Regulation; Antiviral Agents; Cell Survival; Hep G2 Cells; Hepacivirus; HSC70 Heat-Shock Proteins; Humans; Structure-Activity Relationship; Viral Proteins; Virus Replication | 2018 |